Actively Recruiting
Adding Local Ablative Therapy to Ongoing Systemic Treatment for Adults With Oligo-Progressive Solid Tumors
Led by University of California, Davis · Updated on 2026-07-08
250
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the clinical benefit of adding locally ablative therapies to ongoing systemic treatment for adults with oligo-progressive solid tumors. This phase 2 pragmatic study aims to assess whether continuing systemic therapy combined with local ablative treatments can improve disease control, with the primary goal being the time to treatment failure following the local therapy. The study is conducted at a single site and focuses on several types of solid tumors including breast, gynecological, head and neck, sarcomas, and other specified solid malignancies. Participants will receive locally ablative therapies, which include stereotactic ablative radiotherapy SABR or interventional radiology IR ablation, alongside their current systemic cancer treatments. The choice of local ablative therapy is determined by the treating radiation oncologist or interventional radiologist based on standard practices. The study monitors participants for up to 5 years after receiving the local therapy to evaluate disease control and other outcomes. During the study, participants continue their systemic therapy with no more than a 30-day break for the local ablative treatment. Researchers will regularly assess disease status and treatment effects through clinical evaluations and monitor for adverse events related to the ablative therapies. The primary outcome is disease control at 3 months after starting local therapy, with additional measures including adverse events, overall survival, and time to treatment failure tracked up to 1 to 2 years. Participants are closely followed to gather information on treatment response and safety over the course of the study.
CONDITIONS
Brief Title
Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
Research Team
O
Office of Clinical Research
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here